| Quality of life in a hospice: a validation of the Croatian version of the EORTC QLQ-C15-PAL M Golčić, R Dobrila-Dintinjana, G Golčić, I Pavlović-Ružić, A Stevanović, ... American Journal of Hospice and Palliative Medicine® 35 (8), 1085-1090, 2018 | 17 | 2018 |
| The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting M Golčić, R Dobrila-Dintinjana, G Golčić, A Čubranić Journal of pain and symptom management 55 (1), 22-30, 2018 | 15 | 2018 |
| Burkitt lymphoma in gastrointestinal tract: a report of two cases A Čubranić, M Golčić, D Fučkar-Čupić, B Brozović, D Gajski, I Brumini Acta Clinica Croatica 58 (2.), 386-390, 2019 | 10 | 2019 |
| Physical exercise: an evaluation of a new clinical biomarker of survival in hospice patients M Golčić, R Dobrila-Dintinjana, G Golčić, L Gović-Golčić, A Čubranić American Journal of Hospice and Palliative Medicine® 35 (11), 1377-1383, 2018 | 10 | 2018 |
| Do physicians underestimate pain in terminal cancer patients? A prospective study in a hospice setting M Golcic, R Dobrila-Dintinjana, G Golcic, I Pavlovic-Ružic, L Govic-Golcic The Clinical journal of pain 34 (12), 1159-1163, 2018 | 8 | 2018 |
| Changes in metabolic profile, iron and ferritin levels during the treatment of metastatic renal cancer–A new potential biomarker? M Golčić, M Petković Medical hypotheses 94, 148-150, 2016 | 7 | 2016 |
| Smoking cessation after a cancer diagnosis: a cross-sectional analysis in the setting of a developing country M Golčić, I Tomaš, A Stevanović, G Golčić, R Dobrila-Dintinjana, S Erić, ... Clinics and Practice 11 (3), 509-519, 2021 | 6 | 2021 |
| Relative change in S100 as a biomarker of survival in patients with metastatic melanoma treated with pembrolizumab L Simetić, K Blažičević, K MEĐUGORAC, M GOLČIĆ, D Herceg Anticancer Research 40 (4), 2157-2163, 2020 | 5 | 2020 |
| Evaluation of systemic treatment options for gastrointestinal stromal tumours M Golčić, RL Jones, P Huang, A Napolitano Cancers 15 (16), 4081, 2023 | 4 | 2023 |
| Could fecal microbial transplantation offer a new potential in the treatment of metastatic pancreatic ductal adenocarcinoma? M Golčić, L Simetić, T Majnarić, G Golčić, D Herceg Medical hypotheses 161, 110801, 2022 | 4 | 2022 |
| Should we treat pain in the elderly palliative care cancer patients differently? M Golčić, R Dobrila-Dintinjana, G Golčić, I Plavšić, L Gović-Golčić, ... Acta Clinica Croatica 59 (3), 387, 2020 | 4 | 2020 |
| Differences between transdermal fentanyl and buprenorphine in the elderly hospice patients M Golčić, R Dobrila-Dintinjana, G Golčić, L Gović-Golčić Pain research and treatment 2018, 2018 | 4 | 2018 |
| Analysis of the gut microbiome and dietary habits in metastatic melanoma patients with a complete and sustained response to immunotherapy M Golčić, L Simetić, D Herceg, K Blažičević, G Kenđel Jovanović, I Dražić, ... Cancers 15 (11), 3052, 2023 | 3 | 2023 |
| Analysis of clinical factors associated with survival in patients with soft-tissue sarcoma receiving trabectedin L Simetić, K Blažičević, T Ladenhauser, M Golčić, T Majnarić, D Herceg Anti-cancer drugs 32 (10), 1058-1066, 2021 | 2 | 2021 |
| Analiza potencijalno nepotrebnih lijekova u hospicijskoj skrbi koristeći OncPal smjernice za depreskripciju M Golčić, R Dobrila-Dintinjana, G Golčić, L Gović-Golčić, ... Medicina Fluminensis: Medicina Fluminensis 57 (2), 177-182, 2021 | 1 | 2021 |
| Palliative and Hospice Care in the Republic of Croatia: An Overview and Personal Experience R Dobrila-Dintinjana, M Golčić Palliative Care for Chronic Cancer Patients in the Community: Global …, 2021 | 1 | 2021 |
| How do Hospice Patients Feel about Hospice Care-and is It Important? Exploring the Relationship between Patient Attitude to Hospice Care, Survival and other Patient … M Golčić, R Dobrila-Dintinjana, G Golčić, L Gović-Golčić, A Čubranić, ... Clinical Social Work and Health Intervention 8 (4), 53-60, 2017 | 1 | 2017 |
| Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions? A Čubranić, R Dobrila-Dintinjana, A Redžović, M Dintinjana, D Petranović, ... Medical hypotheses 96, 16-19, 2016 | 1 | 2016 |
| Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients D Vucinic, I Skocilic, M Golcic, R Dobrila-Dintinjana, M Kolak, I Jerkovic, ... Journal of Personalized Medicine 14 (3), 278, 2024 | | 2024 |
| Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer? M Golčić, A Belančić Diabetology 4 (4), 553-559, 2023 | | 2023 |
Luka SimeticKBC ZAGREBVerified email at student.mef.hr
